Glenmede Trust Co. NA Acquires 40,231 Shares of Agilent Technologies, Inc. (NYSE:A)

Glenmede Trust Co. NA increased its holdings in Agilent Technologies, Inc. (NYSE:A) by 54.1% in the third quarter, Holdings Channel.com reports. The firm owned 114,638 shares of the medical research company’s stock after acquiring an additional 40,231 shares during the period. Glenmede Trust Co. NA’s holdings in Agilent Technologies were worth $17,021,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in A. Cetera Investment Advisers increased its stake in Agilent Technologies by 953.3% in the 1st quarter. Cetera Investment Advisers now owns 32,694 shares of the medical research company’s stock worth $4,757,000 after purchasing an additional 29,590 shares during the period. Marshall Financial Group LLC purchased a new position in shares of Agilent Technologies in the second quarter worth $1,058,000. Van ECK Associates Corp raised its holdings in Agilent Technologies by 6.6% during the 3rd quarter. Van ECK Associates Corp now owns 2,976,905 shares of the medical research company’s stock valued at $442,011,000 after buying an additional 183,716 shares during the last quarter. AXA S.A. boosted its position in Agilent Technologies by 32.3% during the 2nd quarter. AXA S.A. now owns 362,945 shares of the medical research company’s stock valued at $47,049,000 after buying an additional 88,667 shares during the period. Finally, Empowered Funds LLC grew its holdings in Agilent Technologies by 29.8% in the 3rd quarter. Empowered Funds LLC now owns 30,978 shares of the medical research company’s stock worth $4,592,000 after acquiring an additional 7,111 shares during the last quarter. Institutional investors own 87.42% of the company’s stock.

Analyst Ratings Changes

A has been the subject of a number of analyst reports. UBS Group increased their target price on shares of Agilent Technologies from $141.00 to $150.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd. Bank of America lifted their price objective on Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a research report on Thursday, August 22nd. Sanford C. Bernstein decreased their target price on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a report on Tuesday. JPMorgan Chase & Co. cut their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Tuesday. Finally, Stifel Nicolaus reaffirmed a “buy” rating and issued a $151.00 target price on shares of Agilent Technologies in a research report on Monday, August 26th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat.com, Agilent Technologies has an average rating of “Hold” and an average target price of $143.40.

Agilent Technologies Price Performance

Shares of A opened at $138.14 on Friday. Agilent Technologies, Inc. has a twelve month low of $124.10 and a twelve month high of $155.35. The company has a market capitalization of $39.69 billion, a P/E ratio of 28.66, a price-to-earnings-growth ratio of 5.91 and a beta of 1.07. The firm has a 50 day moving average of $137.65 and a 200 day moving average of $137.44. The company has a quick ratio of 1.37, a current ratio of 1.78 and a debt-to-equity ratio of 0.36.

Agilent Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 22nd. Stockholders of record on Tuesday, December 31st will be paid a $0.248 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $0.99 annualized dividend and a dividend yield of 0.72%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s payout ratio is currently 20.54%.

Insider Activity

In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of the business’s stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the sale, the senior vice president now directly owns 40,011 shares in the company, valued at approximately $5,801,595. The trade was a 19.98 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.33% of the company’s stock.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.